Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 9, 2026 · Item 3.01
Jasper Therapeutics, Inc.
7
Item 3.01
Jun 9, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 3.01 |
| Primary topic | Item 3.01 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Jasper Therapeutics, Inc. filed this 8-K to disclose: 0001788028 2026-06-03 2026-06-03 0001788028 JSPR:VotingCommonStockParValue0. 0001PerShareMember 2026-06-03 2026-06-03 0001788028 JSPR:RedeemableWarrantsEachTenWarrantsExercisableForOneShareOfVotingCommonStockAtExercisePriceOf115. |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 3, 2026 |
| Accession number | 0001213900-26-066782 |
| Reported items | Item 3.01 See Analysis tab for workforce implications |
